Literature DB >> 7695315

High efficacy of short-term quinine-antibiotic combinations for treating adult malaria patients in an area in which malaria is hyperendemic.

W Metzger1, B Mordmüller, W Graninger, U Bienzle, P G Kremsner.   

Abstract

In a randomized trial, a three-dose quinine monotherapy was compared with short-term combination regimens of quinine-clindamycin and quinine-doxycycline for treating adult Gabonese patients with Plasmodium falciparum malaria. In quinine-treated patients, only 38% were ultimately cured. In contrast, more than 90% of patients were cured after treatment with either combination regimen.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7695315      PMCID: PMC162517          DOI: 10.1128/AAC.39.1.245

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

Review 1.  The dynamics of drug resistance in Plasmodium falciparum.

Authors:  W H Wernsdorfer; D Payne
Journal:  Pharmacol Ther       Date:  1991       Impact factor: 12.310

Review 2.  Clindamycin in malaria treatment.

Authors:  P G Kremsner
Journal:  J Antimicrob Chemother       Date:  1990-01       Impact factor: 5.790

3.  A comparative trial of three regimens for treating uncomplicated falciparum malaria in Acre, Brazil.

Authors:  P G Kremsner; G M Zotter; H Feldmeier; W Graninger; R M Rocha; G Wiedermann
Journal:  J Infect Dis       Date:  1988-12       Impact factor: 5.226

4.  [Use of tetracycline and quinine combination in the treatment of Plasmodium falciparum malaria].

Authors:  L C Barata; M Boulos; A P Dutra
Journal:  Rev Soc Bras Med Trop       Date:  1986 Jul-Sep       Impact factor: 1.581

5.  Comparison of micronized halofantrine with chloroquine-antibiotic combinations for treating Plasmodium falciparum malaria in adults from Gabon.

Authors:  P G Kremsner; E Wildling; L Jenne; W Graninger; U Bienzle
Journal:  Am J Trop Med Hyg       Date:  1994-06       Impact factor: 2.345

6.  Treatment of falciparum malaria with clindamycin.

Authors:  D G Rivera; B D Cabrera; N T Lara
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1982 Nov-Dec       Impact factor: 1.846

7.  [Treatment of malaria (P. falciparum) with clindamycin. II - Dosage schedule for 5 days].

Authors:  W D Alecrim; B C Albuquerque; M G Alecrim; H Dourado
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1982 Nov-Dec       Impact factor: 1.846

8.  Quinine with tetracycline for the treatment of drug-resistant falciparum malaria in Thailand.

Authors:  G Watt; L Loesuttivibool; G D Shanks; E F Boudreau; A E Brown; K Pavanand; H K Webster; S Wechgritaya
Journal:  Am J Trop Med Hyg       Date:  1992-07       Impact factor: 2.345

9.  Susceptibility of Plasmodium falciparum to different doses of quinine in vivo and to quinine and quinidine in vitro in relation to chloroquine in Liberia.

Authors:  A Björkman; M Willcox; N Marbiah; D Payne
Journal:  Bull World Health Organ       Date:  1991       Impact factor: 9.408

10.  Intravenous quinine therapy of hospitalized children with Plasmodium falciparum malaria in Kinshasa, Zaire.

Authors:  A E Greenberg; P Nguyen-Dinh; F Davachi; B Yemvula; N Malanda; M Nzeza; S B Williams; J F de Zwart; M Nzeza
Journal:  Am J Trop Med Hyg       Date:  1989-04       Impact factor: 2.345

View more
  12 in total

1.  Controlled trial of 3-day quinine-clindamycin treatment versus 7-day quinine treatment for adult travelers with uncomplicated falciparum malaria imported from the tropics.

Authors:  P Parola; S Ranque; S Badiaga; M Niang; O Blin; J J Charbit; J Delmont; P Brouqui
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

Review 2.  Clindamycin as an antimalarial drug: review of clinical trials.

Authors:  Bertrand Lell; Peter G Kremsner
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

3.  Pharmacokinetics of oral doxycycline during combination treatment of severe falciparum malaria.

Authors:  Paul N Newton; Jean-François Chaulet; Alan Brockman; Wirongrong Chierakul; Arjen Dondorp; Ronatrai Ruangveerayuth; Sornchai Looareesuwan; Cyril Mounier; Nicholas J White
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

Review 4.  Clindamycin plus quinine for treating uncomplicated falciparum malaria: a systematic review and meta-analysis.

Authors:  Charles O Obonyo; Elizabeth A Juma
Journal:  Malar J       Date:  2012-01-04       Impact factor: 2.979

5.  New medicines for malaria.

Authors:  Benjamin Mordmüller
Journal:  Wien Klin Wochenschr       Date:  2010-03       Impact factor: 1.704

6.  No evidence for transmission of antibiotic-resistant Escherichia coli strains from humans to wild western lowland gorillas in Lopé National Park, Gabon.

Authors:  Julio Andre Benavides; Sylvain Godreuil; Rebecca Bodenham; Sandra Ratiarison; Céline Devos; Marie-Odile Petretto; Michel Raymond; Patricia Escobar-Páramo
Journal:  Appl Environ Microbiol       Date:  2012-04-06       Impact factor: 4.792

7.  Need for optimized dosages in the design of comparative clinical trials of anti-malarial drugs.

Authors:  Sanjeev Krishna; Peter G Kremsner
Journal:  Malar J       Date:  2022-06-20       Impact factor: 3.469

Review 8.  Should we abandon quinine plus antibiotic for treating uncomplicated falciparum malaria? A systematic review and meta-analysis of randomized controlled trials.

Authors:  Tianzhang Song; Jintao Chen; Lilin Huang; Wenjia Gan; Hongling Yin; Juan Jiang; Tailong He; Huaiqiu Huang; Xuchu Hu
Journal:  Parasitol Res       Date:  2015-12-14       Impact factor: 2.289

9.  Quinine plus clindamycin improves chemotherapy of severe malaria in children.

Authors:  P G Kremsner; P Radloff; W Metzger; E Wildling; B Mordmüller; J Philipps; L Jenne; M Nkeyi; J Prada; U Bienzle
Journal:  Antimicrob Agents Chemother       Date:  1995-07       Impact factor: 5.191

Review 10.  Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria.

Authors:  Jane Achan; Ambrose O Talisuna; Annette Erhart; Adoke Yeka; James K Tibenderana; Frederick N Baliraine; Philip J Rosenthal; Umberto D'Alessandro
Journal:  Malar J       Date:  2011-05-24       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.